Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. vs SAMRAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIKAL. SAMRAT PHARMA HIKAL./
SAMRAT PHARMA
 
P/E (TTM) x 32.4 8.8 366.1% View Chart
P/BV x 3.5 5.1 68.4% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 HIKAL.   SAMRAT PHARMA
EQUITY SHARE DATA
    HIKAL.
Mar-21
SAMRAT PHARMA
Mar-21
HIKAL./
SAMRAT PHARMA
5-Yr Chart
Click to enlarge
High Rs204159 128.6%   
Low Rs6758 115.7%   
Sales per share (Unadj.) Rs139.5497.3 28.1%  
Earnings per share (Unadj.) Rs10.817.3 62.6%  
Cash flow per share (Unadj.) Rs17.718.9 93.9%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs75.795.9 78.9%  
Shares outstanding (eoy) m123.303.09 3,990.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.00.2 446.0%   
Avg P/E ratio x12.66.3 200.0%  
P/CF ratio (eoy) x7.75.8 133.2%  
Price / Book Value ratio x1.81.1 158.5%  
Dividend payout %18.50-   
Avg Mkt Cap Rs m16,738335 4,993.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,64311 15,589.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m17,2041,537 1,119.6%  
Other income Rs m505 1,076.0%   
Total revenues Rs m17,2541,541 1,119.5%   
Gross profit Rs m3,22987 3,732.4%  
Depreciation Rs m8525 17,291.1%   
Interest Rs m36213 2,834.6%   
Profit before tax Rs m2,06473 2,810.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73320 3,644.2%   
Profit after tax Rs m1,33153 2,496.5%  
Gross profit margin %18.85.6 333.4%  
Effective tax rate %35.527.4 129.7%   
Net profit margin %7.73.5 223.0%  
BALANCE SHEET DATA
Current assets Rs m9,251473 1,954.9%   
Current liabilities Rs m7,033273 2,573.7%   
Net working cap to sales %12.913.0 99.1%  
Current ratio x1.31.7 76.0%  
Inventory Days Days262 1,649.6%  
Debtors Days Days10378,397,170 0.0%  
Net fixed assets Rs m10,906101 10,826.7%   
Share capital Rs m24731 798.1%   
"Free" reserves Rs m9,087265 3,423.1%   
Net worth Rs m9,334296 3,149.4%   
Long term debt Rs m2,6290-   
Total assets Rs m20,157574 3,511.9%  
Interest coverage x6.76.8 99.3%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.92.7 31.9%   
Return on assets %8.411.5 72.9%  
Return on equity %14.318.0 79.3%  
Return on capital %20.329.1 69.7%  
Exports to sales %68.78.9 772.9%   
Imports to sales %26.986.8 30.9%   
Exports (fob) Rs m11,823137 8,653.7%   
Imports (cif) Rs m4,6231,334 346.5%   
Fx inflow Rs m11,823137 8,653.7%   
Fx outflow Rs m4,6231,334 346.5%   
Net fx Rs m7,200-1,198 -601.2%   
CASH FLOW
From Operations Rs m2,29048 4,737.6%  
From Investments Rs m-1,562-29 5,343.7%  
From Financial Activity Rs m-969-19 5,125.3%  
Net Cashflow Rs m-2400 -114,504.8%  

Share Holding

Indian Promoters % 68.8 49.7 138.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.8 3.2 148.1%  
FIIs % 3.9 3.2 120.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.2 50.4 62.0%  
Shareholders   79,105 4,768 1,659.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIKAL. With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    CIPLA    AUROBINDO PHARMA    



Today's Market

SGX Nifty Trades Flat, Adani Enters Alumina and Iron Ore Business, ICICI Bank Hits Rs 6-tn in Market Cap, and Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets rose tracking the rally in US stocks after softer-than-expected US inflation data stoked speculation the Federal Reserve could pivot to a shallower pace of interest-rate hikes.